Arradiance adds Dr. Jill Becker to board
Arradiance named ALD pioneer Dr. Jill S. Becker to its Board of Directors on July 29, 2026, as the Littleton, Massachusetts company looks to speed strategic growth. The appointment brings added commercialization, fundraising and governance experience to a company that sells compact ALD equipment and coating services.
Why it matters: - Dr. Jill Becker brings commercialization experience in atomic layer deposition, a field central to Arradiance’s business. - The appointment adds board-level support as Arradiance pursues strategic growth and broader commercial reach. - Becker’s background spans startups, fundraising, partnerships, and corporate governance.
What happened: - Arradiance appointed Dr. Jill S. Becker to its Board of Directors on July 29, 2026. - The company is based in Littleton, Massachusetts. - Arradiance said the appointment is aimed at helping accelerate strategic growth.
The details: - Becker is an inventor, deep technology entrepreneur, CEO, and strategic advisor with more than 25 years of experience turning scientific discoveries into companies. - She is recognized as a pioneer in the commercialization of atomic layer deposition, or ALD, technology. - Becker founded Cambridge NanoTech based on Harvard Ph.D. research and built it into a market leader for research, pilot-scale, and manufacturing ALD systems. - She later founded Kebotix, which focused on AI-driven autonomous laboratories for discovering advanced materials, chemicals, and therapeutics. - Through 02139 Inc., Becker advises technology companies, investors, universities, and research institutions on commercialization, strategy, fundraising, mergers and acquisitions, strategic partnerships, turnarounds, and corporate governance. - Becker has served on numerous corporate, nonprofit, and advisory boards and currently serves on the board of Brilliant Matters. - She is a member of the Young Presidents’ Organization and received the Ernst & Young Entrepreneur of the Year Award in Energy & Materials. - Becker earned an Honours B.Sc. in Chemistry from the University of Toronto and A.M. and Ph.D. degrees in Chemistry from Harvard University. - Arradiance CEO Michael Trotter said Becker brings scientific and engineering understanding, entrepreneurial ability, and an extensive network in the ALD field. - Becker said Arradiance has a strong technical foundation, a strong product portfolio, and opportunities to expand commercial impact. - Arradiance includes compact research-grade ALD, plasma-enhanced ALD, and MLD equipment in its product line, including the GEMStar and PRIME platforms. - The company also provides rapid-turn foundry coating services and develops new films and chemistries for customer substrates. - Arradiance said hundreds of its systems are used by commercial, academic, and government research teams across semiconductors, energy, sensors, microelectronics, and other emerging applications. - More information is available on Arradiance’s website.
Between the lines: - The board addition signals Arradiance is prioritizing outside expertise that matches its technology base. - Becker’s mix of technical credibility and operating experience suggests the company wants help with both product development and market expansion. - The appointment also points to a broader push to deepen partnerships and strengthen governance as the company grows.
What's next: - Arradiance said Becker will work with the board and leadership team to accelerate growth and strengthen strategic partnerships. - The company is likely to lean on her network and commercialization background as it expands the reach of its ALD technologies. - Arradiance’s growth agenda appears centered on moving more customers from research use toward production applications.
The bottom line: - Arradiance is adding a proven ALD leader to its board as it tries to turn technical strength into faster commercial growth.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Chemicals Press Releases
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.